Literature DB >> 526928

Phase I study of weekly maytansine given by iv bolus or 24-hour infusion.

A P Chahinian, C Nogeire, T Ohnuma, M L Greenberg, M Sivak, I S Jaffrey, J F Holland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 526928

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

Review 1.  Thymomas. Current experience and future directions in therapy.

Authors:  P J Loehrer
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

2.  Drug-Loaded Photosensitizer-Chitosan Nanoparticles for Combinatorial Chemo- and Photodynamic-Therapy of Cancer.

Authors:  Abhilash D Pandya; Anders Øverbye; Priyanka Sahariah; Vivek S Gaware; Håkon Høgset; Màr Masson; Anders Høgset; Gunhild M Mælandsmo; Tore Skotland; Kirsten Sandvig; Tore-Geir Iversen
Journal:  Biomacromolecules       Date:  2020-03-05       Impact factor: 6.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.